Literature DB >> 18636744

Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation.

Issam McDoom1, Xianyue Ma, Annet Kirabo, Kuang-Yung Lee, David A Ostrov, Peter P Sayeski.   

Abstract

Jak2 is a 130 kDa tyrosine kinase that is important in a number of cellular signaling pathways. Its function is intrinsically regulated by the phosphorylation of a handful of its 49 tyrosines. Here, we report that tyrosine 972 (Y972) is a novel site of Jak2 phosphorylation and, hence, autoregulation. Specifically, we found that Y972 is phosphorylated and confirmed that this residue resides on the surface of the protein. Using expression plasmids that expressed either wild-type Jak2 or a full-length Jak2 cDNA containing a single Y972F substitution mutation, we investigated the consequences of losing Y972 phosphorylation on Jak2 function. We determined that the loss of Y972 phosphorylation significantly reduced the levels of both Jak2 total tyrosine phosphorylation and phosphorylation of Y1007/Y1008. Additionally, Y972 phosphorylation was shown to be important for maximal kinase function. Interestingly, in response to classical cytokine activation, the Jak2 Y972F mutant exhibited a moderately impaired level of activation when compared to the wild-type protein. However, when Jak2 was activated via a GPCR ligand, the ability of the Y972F mutant to be activated was completely lost, therefore suggesting a differential role of Y972 in Jak2 activation. Finally, we found that phosphorylation of Y972 enhances Jak2 kinase function via a mechanism that appears to stabilize the active conformation of the protein. Collectively, our results suggest that Y972 is a novel site of Jak2 phosphorylation and plays an important differential role in ligand-dependent Jak2 activation via a mechanism that involves stabilization of the Jak2 active conformation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636744      PMCID: PMC3636534          DOI: 10.1021/bi800867d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR.

Authors:  P P Sayeski; M S Ali; S J Frank; K E Bernstein
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

2.  Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor.

Authors:  M S Ali; P P Sayeski; K E Bernstein
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

3.  Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2.

Authors:  Megumi Funakoshi-Tago; Stephane Pelletier; Tadashi Matsuda; Evan Parganas; James N Ihle
Journal:  EMBO J       Date:  2006-10-05       Impact factor: 11.598

Review 4.  SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other.

Authors:  Travis J Maures; Jason H Kurzer; Christin Carter-Su
Journal:  Trends Endocrinol Metab       Date:  2006-11-30       Impact factor: 12.015

5.  Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.

Authors:  M H Tomasson; I R Williams; S Li; J Kutok; D Cain; S Gillessen; G Dranoff; R A Van Etten; D G Gilliland
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

6.  Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Authors:  Lawrence S Argetsinger; Jean-Louis K Kouadio; Hanno Steen; Allan Stensballe; Ole N Jensen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.

Authors:  Ning Yang; Xiangdong Wang; Jing Jiang; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2007-04-24

8.  Vaccinia virus-mediated high level expression and single step purification of recombinant Jak2 protein.

Authors:  Xianyue Ma; Peter P Sayeski
Journal:  Protein Expr Purif       Date:  2004-06       Impact factor: 1.650

9.  Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.

Authors:  Jason H Kurzer; Lawrence S Argetsinger; Yong-Jie Zhou; Jean-Louis K Kouadio; John J O'Shea; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state.

Authors:  Kiranam Chatti; William L Farrar; Roy J Duhé
Journal:  Biochemistry       Date:  2004-04-13       Impact factor: 3.162

View more
  7 in total

1.  Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Authors:  Jacqueline Sayyah; Kavitha Gnanasambandan; Sushama Kamarajugadda; Shigeharu Tsuda; Jennifer Caldwell-Busby; Peter P Sayeski
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

2.  Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity.

Authors:  Lawrence S Argetsinger; Jeanne A Stuckey; Scott A Robertson; Rositsa I Koleva; Joel M Cline; Jarrod A Marto; Martin G Myers; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2010-03-19

Review 3.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

4.  Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.

Authors:  Dongqing Yan; Robert E Hutchison; Golam Mohi
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

5.  Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.

Authors:  Joshua J Oaks; Ramasamy Santhanam; Christopher J Walker; Steve Roof; Jason G Harb; Greg Ferenchak; Ann-Kathrin Eisfeld; James R Van Brocklyn; Roger Briesewitz; Sahar A Saddoughi; Kyosuke Nagata; Robert Bittman; Michael A Caligiuri; Omar Abdel-Wahab; Ross Levine; Ralph B Arlinghaus; Alfonso Quintas-Cardama; John M Goldman; Jane Apperley; Alistair Reid; Dragana Milojkovic; Mark T Ziolo; Guido Marcucci; Besim Ogretmen; Paolo Neviani; Danilo Perrotti
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

6.  Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling.

Authors:  Scott A Robertson; Rositsa I Koleva; Lawrence S Argetsinger; Christin Carter-Su; Jarrod A Marto; Edward P Feener; Martin G Myers
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

7.  Three dimensional quantitative structure-activity relationship of 5H-Pyrido[4,3-b]indol-4-carboxamide JAK2 inhibitors.

Authors:  Xiaoyun Wu; Shanhe Wan; Jiajie Zhang
Journal:  Int J Mol Sci       Date:  2013-06-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.